Respiratory
1 drug is in development for SARS-CoV-2.
- Companies
- 1
- Clinical trials
- 18
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the SARS-CoV-2 pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| ub-612 | Vaxxinity, Inc. (VAXX) |
About this indication
SARS-CoV-2 context
Respiratory·MeSH: COVID-19 (D000086382)
Narrower concept of MeSH descriptor COVID-19
Frequently asked questions
How many drugs are in development for SARS-CoV-2?
BioSniper tracks 1 drug in development for SARS-CoV-2 across 1 company.
How many clinical trials target SARS-CoV-2?
There are 18 clinical trials targeting SARS-CoV-2 tracked by BioSniper.